suPARnostic® TurbiLatex will now be available for clinical decision making in the Emergency Department of Complejo Asistencial Universitario de León (León Hospital) in Spain, and it will be the first hospital in Spain to implement suPARnostic® in clinical routine.
León Hospital is a 1056-bed university hospital in the Castilla y León region in Spain.
In addition to using suPAR as a routine marker for triaging of acute medical patients in the Emergency Department to avoid unnecessary admissions, suPARnostic® will also be used to triage patients admitted to the hospital with suspicion of a COVID-19 infection.
Jakob Knudsen, CEO of ViroGates, says:
“We are looking forward to a long-term collaboration with León Hospital using suPARnostic® to support triaging of acute medical patients in the Emergency Department.
We are, however, especially honoured to help during the COVID-19 outbreak for Léon Hospital to be able to better cope with the extraordinary workload associated with the high number of patients in need of care, and the prioritizations needed to allocate resources optimally.”